Annex Advisory Services LLC Invests $802,000 in Oscar Health, Inc. $OSCR

Key Points

• Annex Advisory Services LLC acquired a new stake in Oscar Health, purchasing 37,394 shares valued at approximately $802,000 during the second quarter.
• Despite the investment interest, Oscar Health's stock has seen declining ratings with multiple analysts lowering their target prices, and the stock currently holds an average rating of "Strong Sell."
• Oscar Health reported a loss of ($0.89) EPS for the last quarter, which was better than expected but still highlighted a negative return on equity of 13.78%.

Annex Advisory Services LLC bought a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 37,394 shares of the company's stock, valued at approximately $802,000.

Other large investors have also recently bought and sold shares of the company. Jones Financial Companies Lllp increased its stake in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after acquiring an additional 2,242 shares in the last quarter. Strs Ohio purchased a new position in shares of Oscar Health during the 1st quarter valued at $30,000. Larson Financial Group LLC increased its position in shares of Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after purchasing an additional 2,512 shares during the last quarter. CWM LLC grew its position in Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after acquiring an additional 1,078 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its position in Oscar Health by 484.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock valued at $45,000 after acquiring an additional 2,854 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have commented on OSCR shares. UBS Group restated a "sell" rating and issued a $11.00 price objective (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Wall Street Zen lowered Oscar Health from a "hold" rating to a "sell" rating in a research note on Saturday, August 9th. Wells Fargo & Company cut shares of Oscar Health from an "equal weight" rating to an "underweight" rating and cut their price objective for the company from $16.00 to $10.00 in a research report on Friday, July 11th. Barclays decreased their price objective on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research report on Wednesday, July 23rd. Finally, Raymond James Financial downgraded shares of Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Four investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Strong Sell" and a consensus price target of $12.07.

Oscar Health Stock Down 2.5%

Shares of NYSE OSCR traded down $0.47 during mid-day trading on Monday, reaching $18.50. The company had a trading volume of 18,329,575 shares, compared to its average volume of 16,117,552. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.09. The stock has a fifty day moving average of $16.26 and a two-hundred day moving average of $15.28. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. The company has a market capitalization of $4.78 billion, a price-to-earnings ratio of -22.84 and a beta of 1.87.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.01. The firm had revenue of $2.86 billion during the quarter, compared to analysts' expectations of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The company's revenue for the quarter was up 29.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.20 EPS. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.